Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?

Elena Collado-Lledó1, Isaac Llaó1, Mercedes Rivas-Lasarte2

  • 1Intensive Cardiac Care Unit. Cardiology Department, Hospital Universitari de Bellvitge -IDIBELL, Feixa Llarga s/n. 08907. L'Hospitalet de Llobregat, Barcelona, Spain.

Insights

Gender does not significantly impact cardiogenic shock management or outcomes. Both CardShock and IABP-SHOCK II risk scores effectively predict mortality in men and women with cardiogenic shock.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Health Services Research

Background:

  • Early recognition and risk stratification are vital in cardiogenic shock (CS).
  • Women with cardiovascular diseases often show lower adherence to treatment recommendations.
  • Limited data exists on gender-based disparities in CS clinical presentation, management, and risk stratification tool performance.

Purpose of the Study:

  • To investigate potential gender-based differences in the clinical picture, management, and risk stratification tool performance in patients with cardiogenic shock.
  • To evaluate the effectiveness of the CardShock and IABP-SHOCK II risk scores in predicting in-hospital mortality in both male and female patients with CS.

Main Methods:

  • Utilized data from the multicenter Red-Shock registry, including consecutive patients diagnosed with CS.
  • Calculated CardShock and IABP-SHOCK II risk scores for all included patients.
  • Assessed the discriminative ability of risk scores by gender using binary logistic regression and Receiver Operating Characteristic (ROC) curves with Area Under the Curve (AUC).

Main Results:

  • A total of 793 patients were analyzed (28% female). Women were older and less likely to have COPD or prior MI.
  • Cardiogenic shock in women was less frequently associated with acute coronary syndromes (ACS).
  • In-hospital mortality was 43.6% and not significantly different between genders (p=0.194). Both CardShock (AUC 0.69/0.735) and IABP-SHOCK II (AUC 0.693/0.722) scores accurately predicted mortality in men and women.

Conclusions:

  • No significant gender-based differences were found in the management or in-hospital mortality of cardiogenic shock patients.
  • The CardShock and IABP-SHOCK II risk scores demonstrate good predictive ability for mortality in women with cardiogenic shock, similar to men.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
206
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
190
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
300
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
184
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
201